Osmotica Pharmaceutical Corp.
Osmotica Pharmaceutical Corp. (United States) has no DMF, CEP or site registration linked in our records. 4 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Osmotica Pharmaceutical Corp.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/osmotica-pharmaceutical-corp
Overview
Osmotica Pharmaceutical Corp. is a pharmaceutical company headquartered in Bridgewater, United States.
FDA compliance signals
4 FDA enforcement records linked to this company.
- recall — Class III2018-03-14
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
- recall — Class III2017-12-27
Subpotent Drug
- recall — Class III2017-12-27
Subpotent Drug
- recall — Class III2013-10-09
Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.
Is this Osmotica Pharmaceutical Corp.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.